文献速递系统性红斑狼疮其他结缔组织病

可溶性Flt-1、胎盘生长因子与血管内皮生长因子血清水平用于鉴别妊娠期活动性狼疮肾炎与子痫前期

Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-04-03

该研究纳入71例妊娠期系统性红斑狼疮(SLE)患者,分为非活动性SLE组(41例)、活动性狼疮肾炎组(15例)和子痫前期组(15例),检测分娩前3周内血清VEGF、PlGF和sFlt-1水平。结果发现子痫前期患者sFlt-1和sFlt-1:PlGF比值显著升高、PlGF显著降低,而活动性狼疮肾炎患者VEGF水平较高,提示这些标志物有助于鉴别诊断。

要点

  • 子痫前期患者sFlt-1及sFlt-1:PlGF比值显著高于非活动性SLE和活动性狼疮肾炎患者。
  • 子痫前期患者PlGF水平显著低于非活动性SLE和活动性狼疮肾炎患者。
  • 活动性狼疮肾炎患者VEGF水平高于子痫前期和非活动性SLE患者。

核心结论

  • 检测血清VEGF、PlGF和sFlt-1水平有助于在妊娠期鉴别子痫前期、非活动性SLE和活动性狼疮肾炎。

研究设计与样本

  • 纳入71例妊娠期SLE患者,均为单胎妊娠且无其他自身免疫病,按疾病活动性和子痫前期 presence 分组。
  • 分娩前3周内采集血清样本冻存,采用酶联免疫吸附法进行盲法分析。

主要发现

  • 子痫前期组sFlt-1平均水平和sFlt-1:PlGF比值显著高于非活动性SLE组和活动性狼疮肾炎组。
  • 子痫前期组PlGF平均水平显著低于非活动性SLE组和活动性狼疮肾炎组。
  • 活动性狼疮肾炎组VEGF平均水平高于子痫前期组和非活动性SLE组。

关键数值与推荐

  • 非活动性SLE组41例,SLEPDAI评分<4;活动性狼疮肾炎组15例,SLEPDAI评分≥4且包括肾脏标准;子痫前期组15例。

临床怎么用

  • 妊娠期SLE患者出现疑似子痫前期或狼疮肾炎活动时,可结合血清sFlt-1、PlGF、VEGF及sFlt-1:PlGF比值辅助鉴别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate mean serum levels of vascular endothelial growth factor (VEGF), placental growth factor (PlGF), and soluble Flt-1 (sFlt-1) in pregnant patients with systemic lupus erythematosus (SLE) with inactive disease, active lupus nephritis, and preeclampsia for differential diagnosis between these conditions. METHODS: Pregnant women with SLE, with singleton pregnancies and no other autoimmune diseases, were classified according to disease activity (inactive SLE and active lupus nephritis) and the presence of preeclampsia. Serum samples were collected within 3 weeks of delivery and frozen for subsequent blinded analysis through the enzyme-linked immunosorbent assay method. RESULTS: A total of 71 women were included, with 41 classified as having inactive SLE (group 1; Systemic Lupus Erythematosus Pregnancy Disease Activity Index [SLEPDAI] score <4), 15 with a diagnosis of active lupus nephritis (group 2, SLEPDAI score ≥4, including renal criteria), and 15 with a diagnosis of preeclampsia (group 3). Patients in group 3 had higher mean levels of sFlt-1 and lower mean levels of PlGF compared to groups 1 and 2, both findings with statistical significance. The sFlt-1:PlGF ratio was also significantly higher in patients with preeclampsia, while mean VEGF levels were higher in pregnant woman with active lupus nephritis compared to patients with preeclampsia or inactive SLE. CONCLUSION: Evaluation of serum VEGF, PlGF, and sFlt-1 levels can differentiate between preeclampsia, inactive SLE, and active lupus nephritis during pregnancy.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. de Jesús GR, Lacerda MI, Rodrigues BC, et al. Soluble Flt-1, Placental Growth Factor, and Vascular Endothelial Growth Factor Serum Levels to Differentiate Between Active Lupus Nephritis During Pregnancy and Preeclampsia. Arthritis Care Res (Hoboken). 2021. PMID: 32583963. doi:10.1002/acr.24360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。